Literature DB >> 23803321

Liver fat accumulation after islet transplantation and graft survival.

Cristiane Bauermann Leitão1, Eduardo Moraes Leao Peixoto, Antonio C Westphalen, Leonor G Mireles-Zavala, Vincenzo Lauriola, Karina Bernetti, Andrea Corrales, Camillo Ricordi, Rodolfo Alejandro.   

Abstract

Our objective is to evaluate if there is an association between liver fat accumulation after islet transplantation (ITx) and graft survival. A cohort study was conducted in 34 subjects with type 1 diabetes postallogeneic ITx. Liver fat content was evaluated by magnetic resonance imaging (MRI) (change in liver signal intensity on in-phase and opposed-phase images). Kaplan-Meier curves and Cox regression analysis were performed with islet dysfunction duration as the dependent variable and fat liver content as an independent one. Values of p < 0.05 were significant (SSPS(®)18.0 and MedCalc(®)12.5). Patients' mean age was 40 ± 8 years (diabetes duration: 31 ± 12 years; male: 41%). Islet survival did not differ in patients without (51 months, 95% CI 40-62 months) or with steatosis (48 months, 95% CI 38-58 months; p = 0.55) during islet dysfunction period. Nevertheless, survival curves appear to separate late in the follow-up, and after 40 months steatosis was associated with shorter graft survival (p log rank = 0.049). This association remained (RR 23.5, 95% CI 1.1-516.0; p = 0.045) after adjustments for possible confounding factors. In this sample of subjects with type 1 diabetes submitted to ITx, steatosis was not associated with islet failure in the whole cohort. However, in subjects with functional islets after 40 months, a shorter graft survival was observed in those with steatosis during the islet dysfunction period, even after adjustments to variables known to be associated with islet failure.

Entities:  

Mesh:

Year:  2013        PMID: 23803321     DOI: 10.3727/096368913X668663

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  5 in total

Review 1.  Allo- and auto-percutaneous intra-portal pancreatic islet transplantation (PIPIT) for diabetes cure and prevention: the role of imaging and interventional radiology.

Authors:  Massimo Venturini; Claudio Sallemi; Paolo Marra; Anna Palmisano; Giulia Agostini; Carolina Lanza; Gianpaolo Balzano; Massimo Falconi; Antonio Secchi; Paolo Fiorina; Lorenzo Piemonti; Paola Maffi; Antonio Esposito; Francesco De Cobelli; Alessandro Del Maschio
Journal:  Gland Surg       Date:  2018-04

Review 2.  Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.

Authors:  Tiago Severo Garcia; Tatiana Helena Rech; Cristiane Bauermann Leitão
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

3.  Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation Within a Biologic Resorbable Scaffold.

Authors:  Dora M Berman; R Damaris Molano; Carmen Fotino; Ulisse Ulissi; Jennifer Gimeno; Armando J Mendez; Norman M Kenyon; Norma S Kenyon; David M Andrews; Camillo Ricordi; Antonello Pileggi
Journal:  Diabetes       Date:  2016-02-25       Impact factor: 9.461

Review 4.  Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations.

Authors:  Jacob A Tatum; Max O Meneveau; Kenneth L Brayman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-02-28       Impact factor: 3.168

Review 5.  Artificial Cell Encapsulation for Biomaterials and Tissue Bio-Nanoengineering: History, Achievements, Limitations, and Future Work for Potential Clinical Applications and Transplantation.

Authors:  Armin Mooranian; Melissa Jones; Corina Mihaela Ionescu; Daniel Walker; Susbin Raj Wagle; Bozica Kovacevic; Jacqueline Chester; Thomas Foster; Edan Johnston; Jafri Kuthubutheen; Daniel Brown; Momir Mikov; Hani Al-Salami
Journal:  J Funct Biomater       Date:  2021-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.